Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Medical Decision Making
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Cantor, S. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cantor, S. B.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Cost - Effectiveness Analysis, Extended Dominance, and Ethics

A Quantitative Assessment

Scott B. Cantor

The principle of extended dominance is applied in incremental cost-effectiveness analysis to eliminate from consideration strategies whose costs and benefits are improved by a mixed strategy of two other alternatives. Ethical considerations arise, however, in that equal care is not provided to all of the population. To explore these concerns, the authors establish a theoretical health care example with three diagnostic strategies. They demonstrate, both algebraically and geometrically, how to calculate the set of all possible mixed strategies that dominate the strategy eliminated by extended dominance. With the consideration of budget constraints, they define the "coefficient of inequity" as the minimum proportion of the pop ulation that would receive an inferior health care strategy if a mixed strategy were to be used instead of the dominated strategy. The implications of cost-effectiveness analysis are made explicit, revealing classic economic concerns about the tradeoff of equity and efficiency. Key words: cost-effectiveness analysis; extended dominance; economics; ethics. (Med Decis Making 1994;14:259-265)

Medical Decision Making, Vol. 14, No. 3, 259-265 (1994)
DOI: 10.1177/0272989X9401400308
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 BMJHome page
G. R Barton, T. H Sach, C. Jenkinson, M. Doherty, A. J Avery, and K. R Muir
Lifestyle interventions for knee pain in overweight and obese adults aged >=45: economic evaluation of randomised controlled trial
BMJ, August 18, 2009; 339(aug18_2): b2273 - b2273.
[Abstract] [Full Text] [PDF]

Home page
 Med Decis MakingHome page
S. Eckermann, A. Briggs, and A. R. Willan
Health Technology Assessment in the Cost-Disutility Plane
Med Decis Making, March 1, 2008; 28(2): 172 - 181.
[Abstract] [PDF]

Home page
 Arch DermatolHome page
E. Losina, R. P. Walensky, A. Geller, F. C. Beddingfield III, L. L. Wolf, B. A. Gilchrest, and K. A. Freedberg
Visual Screening for Malignant Melanoma: A Cost-effectiveness Analysis
Arch Dermatol, January 1, 2007; 143(1): 21 - 28.
[Abstract] [Full Text] [PDF]

Home page
 Med Decis MakingHome page
D. R. Holtgrave
HIV Prevention, Cost-Utility Analysis, and Race/Ethnicity: Methodological Considerations and Recommendations
Med Decis Making, March 1, 2004; 24(2): 181 - 191.
[Abstract] [PDF]

Home page
 Decision AnalysisHome page
S. B. Cantor
Clinical Applications in the Decision Analysis Literature: (Comment on Keefer et al. 2004)
Decision Analysis, March 1, 2004; 1(1): 23 - 25.
[Abstract] [PDF]

Home page
 Med Decis MakingHome page
A. H. Briggs, R. Goeree, G. Blackhouse, and B. J. O'Brien
Probabilistic Analysis of Cost-Effectiveness Models: Choosing between Treatment Strategies for Gastroesophageal Reflux Disease
Med Decis Making, August 1, 2002; 22(4): 290 - 308.
[Abstract] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
M. E. van den Akker-van Marle, M. van Ballegooijen, G. J. van Oortmarssen, R. Boer, and J. D. F. Habbema
Cost-Effectiveness of Cervical Cancer Screening: Comparison of Screening Policies
J Natl Cancer Inst, February 6, 2002; 94(3): 193 - 204.
[Abstract] [Full Text] [PDF]

Home page
 AJPHHome page
B. R. Schackman, S. J. Goldie, M. C. Weinstein, E. Losina, H. Zhang, and K. A. Freedberg
Cost-Effectiveness of Earlier Initiation of Antiretroviral Therapy for Uninsured HIV-Infected Adults
Am J Public Health, September 1, 2001; 91(9): 1456 - 1463.
[Abstract] [Full Text] [PDF]

Home page
 Med Decis MakingHome page
P. A. Ubel, J. Baron, and D. A. Asch
Preference for Equity As a Framing Effect
Med Decis Making, May 1, 2001; 21(3): 180 - 189.
[Abstract] [PDF]

Home page
 Med Decis MakingHome page
A. A. Stinnett and J. Mullahy
Net Health Benefits: A New Framework for the Analysis of Uncertainty in Cost-Effectiveness Analysis
Med Decis Making, April 1, 1998; 18(2): S68 - S80.
[Abstract] [PDF]

Home page
 JAMAHome page
K. A. Freedberg, J. A. Scharfstein, G. R. Seage III, E. Losina, M. C. Weinstein, D. E. Craven, and A. D. Paltiel
The Cost-effectiveness of Preventing AIDS-Related Opportunistic Infections
JAMA, January 14, 1998; 279(2): 130 - 136.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
J. E. Siegel, M. C. Weinstein, L. B. Russell, and M. R. Gold
Recommendations for Reporting Cost-effectiveness Analyses
JAMA, October 23, 1996; 276(16): 1339 - 1341.
[Abstract] [PDF]